|
Volumn 37, Issue 10, 2001, Pages 703-727
|
Osteoporosis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE INHIBITOR;
ALENDRONIC ACID;
ANABOLIC AGENT;
ARZOXIFENE;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITRIOL;
CATHEPSIN K;
CLODRONIC ACID;
CONJUGATED ESTROGEN;
DOXERCALCIFEROL;
ELCATONIN;
ESTRADIOL;
GESTODENE;
INCADRONIC ACID;
IPRIFLAVONE;
LASOFOXIFENE;
MENATETRENONE;
NANDROLONE DECANOATE;
OLPADRONIC ACID;
OSTEOPROTEGERIN;
PARATHYROID HORMONE DERIVATIVE;
PARATHYROID HORMONE[1-34];
RALOXIFENE;
RISEDRONIC ACID;
SALCATONIN;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
STATIN;
STRONTIUM;
TIBOLONE;
TRIMEGESTONE;
UNINDEXED DRUG;
BONE ATROPHY;
BONE DISEASE;
BONE MASS;
BONE REMODELING;
CLINICAL TRIAL;
GENETIC ANALYSIS;
HORMONE SUBSTITUTION;
HUMAN;
OSTEOPOROSIS;
PREVALENCE;
REVIEW;
RISK FACTOR;
|
EID: 0035688233
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (0)
|